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Plasmodium knowlesi can cause severe malaria in 
adults; however, descriptions of clinical disease in children 
are lacking. We reviewed case records of children (age <15 
years) with a malaria diagnosis at Kudat District Hospital, 
serving a largely deforested area of Sabah, Malaysia, during 
January–November 2009. Sixteen children with PCR-
confi rmed P. knowlesi monoinfection were compared with 
14 children with P. falciparum monoinfection diagnosed by 
microscopy or PCR. Four children with knowlesi malaria 
had a hemoglobin level at admission of <10.0 g/dL (lowest 
minimum level 6.4 g/dL). Minimum level platelet counts were 
lower in knowlesi than in falciparum malaria (median 76,500/
μL vs. 156,000/μL; p = 0.01). Most (81%) children with P. 
knowlesi malaria received chloroquine and primaquine; 
median parasite clearance time was 2 days (range 1–5 days). 
P. knowlesi is the most common cause of childhood malaria in 
Kudat. Although infection is generally uncomplicated, anemia 
is common and thrombocytopenia universal. Transmission 
dynamics in this region require additional investigation. 
The simian malaria parasite Plasmodium knowlesi is increasingly recognized as a frequent cause of 
potentially fatal human malaria in adults in Malaysian 
Borneo (1–4). The infection has also been reported in 
peninsular Malaysia (5) and in other Southeast Asian 
countries, including Thailand (6,7), Myanmar (8,9), 
Vietnam (10), the Philippines (11), Indonesian Borneo 
(12–14), and Singapore (15,16). Until recently, P. knowlesi 
had been almost uniformly misdiagnosed by microscopy 
as P. malariae because of its morphologic similarities, 
leading to underestimations of prevalence (1,17). Accurate 
diagnosis therefore requires molecular methods. 
The clinical and laboratory features of P. knowlesi 
infections in adults have been described in Kapit, Sarawak, 
where 107 (70%) of 152 adults with malaria were infected 
with P. knowlesi (3). Although P. knowlesi malaria 
was diagnosed in 8 children, the clinical and laboratory 
features were not described. All previously reported P. 
knowlesi infections that caused clinical disease have been 
in adults (1,2,6,8,11–13,15,18–20). In malaria caused by P. 
falciparum (21) and P. vivax (22), the 2 species that cause 
the greatest number of human malaria cases, well-described 
differences exist between adults and children in terms of 
the clinical epidemiology, disease spectrum, and laboratory 
manifestations of disease. We report the demographic, 
clinical, and laboratory features of P. knowlesi infection 
in children in Kudat, Sabah, a rural coastal farming area 
with little remaining primary rainforest, an epidemiologic 
setting that contrasts with the previously described forested 
areas of Sarawak.
Methods
Study Setting
The study was conducted at Kudat District Hospital 
(KDH) on the northeast tip of Sabah, Malaysia, a coastal 
rural area which has been largely deforested. KDH 
services 5 subdistricts (Tigapapan, Dualog, Matunggung, 
Tambuluran, and the island of Banggi), with a total 
population of 85,000 persons. The Rungus are the most 
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common ethnic group on the mainland, and minority groups 
include ethnic Chinese, Bajaus, Dusuns, and Balabaks.
Ministry of Health policy in Sabah requires that all 
patients with a blood fi lm result that indicates malaria be 
admitted to the hospital and discharged only after smear 
results are negative for 2 consecutive days. Since January 
2009, in response to increasing reports of P. knowlesi 
infections and the diffi culties of diagnosing this species by 
microscopy, it became policy at KDH to send slides that 
had been determined by microscopy to show presence of 
P. malariae to the Sabah State Reference Laboratory for 
PCR confi rmation. In addition, KDH sends ≈15% of all 
blood fi lms positive for other Plasmodium spp. for PCR 
confi rmation.
Retrospective Case Review
We retrospectively searched laboratory microscopy 
records for all blood smear results positive for Plasmodium 
spp. during January 1–November 30, 2009. The patient’s 
age, sex, ethnicity, and address were recorded for all 
positive samples. Microscopy results were matched with 
PCR results.
Medical records were retrieved for all children <15 
years of age who had received a diagnosis of malaria on 
the basis of microscopy results. Demographic, clinical, and 
laboratory details were extracted by using standardized 
data forms, which also included disease response to 
antimalarial treatment. Parasite clearance time was defi ned 
as the number of days until negative smear. Anemia and 
severe anemia were defi ned as hemoglobin levels <11 g/dL 
and <7.1 g/dL (3), respectively.
Laboratory Procedures
Blood fi lms were examined by experienced laboratory 
microscopists at KDH with the parasite count being 
classifi ed in most on a scale of 1 to 4 (1 = 4–40 parasites/
μL, 2 = 41–400 parasites/μL, 3 = 401–4,000 parasites/
μL, 4 = >4,000 parasites/μL), with accurate quantitation 
per microliter being recorded for most blood fi lms that 
showed P. knowlesi, but for only a limited number that 
showed P. falciparum. Hemoglobin level and leukocyte 
and thrombocyte counts were measured on site by using 
automated systems (Sysmex XT1800 [Sysmex Corp., 
Mundelein, IL, USA] and CELL-DYN Sapphire [Abbott 
Diagnostics, Abbott Park, IL, USA]) At the Sabah State 
Reference Laboratory, parasite DNA was extracted, and 
nested PCR was performed for P. falciparum, P. vivax, P. 
malariae, P. ovale, and P. knowlesi by methods described 
(1,23).
Statistical Analysis
Data were analyzed by using Stata statistical software, 
version 10 (StataCorp LP, College Station, TX, USA). 
Proportions were compared by using the χ2 or Fisher exact 
test. Normally distributed and non–normally distributed 
variables were compared by using Student t test and Wilcoxon 
rank-sum test, respectively. For comparison between P. 
falciparum and P. knowlesi cases, the analysis included 
children with PCR-confi rmed P. knowlesi infection, and 
children with P. falciparum infection diagnosed by either 
microscopy or PCR. Children with mixed Plasmodium 
infections were excluded from analysis, as were children 
whose medical records could not be located.
Results
Malaria in All Age Groups
From January 1 through November 30, 2009, 220 
patients at KDH were given a diagnosis of malaria on the 
basis of microscopy results (Figure 1). Of these, 196 (89%) 
had P. malariae monoinfection or mixed infection. PCR 
was performed on samples from 157 (80%) of these patients 
and results were positive for P. knowlesi in 137 (87%); 125 
(91%) of these were P. knowlesi monoinfections. For the 
remaining 20 patients who had been given a diagnosis of P. 
malariae monoinfection or mixed infection by microscopy, 
PCR found undifferentiated Plasmodium spp., negative 
results for Plasmodium spp., and 7 cases of P. falciparum 
infection.
To estimate the fi nal numbers of malaria species, we 
used positive PCR results when possible and microscopy 
results when PCR had not been performed (replacing P. 
malariae with P. knowlesi). Microscopy results were also 
used if PCR result was negative (5 P. knowlesi infections 
and 1 P. knowlesi/P. falciparum infection) or if PCR 
result was positive for Plasmodium spp. (7 P. knowlesi 
infections). Using this method, we found 172 (78%) 
P. knowlesi monoinfections, 29 (13%) P. falciparum 
monoinfections, and 19 (9%) mixed infections (Figure 1). 
A greater proportion of patients with P. knowlesi malaria 
were male (123/172 [72%]) than were those with P. 
falciparum malaria (15/29 [52%]; p = 0.03). Median age 
was higher for those with P. knowlesi infection (median 
32 years, interquartile range [IQR] 19–49 years) than for 
those with P. falciparum infection (median 11 years, IQR 
6–30 years).
Malaria in Children
Of 220 patients with positive results by microscopy, 41 
(19%) were <15 years of age. Microscopy showed that 24 
(59%) children had P. malariae monoinfection, 10 (24%) 
had P. falciparum monoinfection, and 7 (17%) had mixed 
infections (Figure 2). Samples from 17 children with P. 
malariae monoinfection underwent PCR; 16 (94%) showed 
P. knowlesi, and 1 showed mixed P. knowlesi/P. vivax 
infection. Again, fi nal numbers of malaria species were 
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estimated by using PCR results (if available) or microscopy 
(if PCR had not been performed). Accordingly, 24 cases 
(59%) were P. knowlesi, 15 (37%) were P. falciparum, and 
2 were mixed P. knowlesi/P. vivax infections. Children 
thus represented 14% (24/172) of all cases of P. knowlesi 
monoinfection.
Further analysis was confi ned to those children with 
PCR-confi rmed P. knowlesi monoinfection and children 
with P. falciparum monoinfection diagnosed by either 
microscopy or PCR. Medical records were unavailable for 
2 children (1 with P. knowlesi and 1 with P. falciparum 
infection), leaving 16 children with PCR-confi rmed P. 
knowlesi infection and 14 with P. falciparum infection for 
comparison (Table 1).
Demographic Characteristics of Children 
with P. knowlesi Malaria 
Half of the children with PCR-confi rmed P. knowlesi 
malaria were male (Table 1). The mean age was 8.9 (95% 
confi dence interval 7.6–10.3) years. The youngest child 
with P. knowlesi infection was 4 years; all others (15/16; 
94%) were 7–14 years of age. In contrast, children with 
P. falciparum malaria were signifi cantly younger, with a 
mean age of 5.4 years (95% confi dence interval 3.5–7.3; 
range 9 months–11 years; p = 0.002).
Clinical Features of P. knowlesi 
and P. falciparum Malaria
All children had fever or a history of fever. The 
duration of fever before hospital admission appeared 
shorter with knowlesi malaria than with falciparum malaria 
(median 4 days vs. 6.5 days), although this difference 
was not statistically signifi cant. Although documentation 
of clinical features was limited, no child was in a state of 
shock, and no child was reported to be dyspneic, to have 
bleeding complications, or to have any other clinical 
feature or laboratory results that indicated severe malaria 
(24). None of the children who had either knowlesi or 
falciparum malaria died.
Anemia
In 11 (69%) children with P. knowlesi malaria, the 
parasite density was accurately determined at hospital 
admission, with a median of 2,240 (IQR 480–7,200) 
parasites/μL. Only 2 children with P. falciparum malaria 
had parasite densities accurately determined at admission 
(200 and 1,600 parasites/μL). Anemia was common with 
P. knowlesi and P. falciparum infections. At admission, 
9 (56%) children with P. knowlesi infection were anemic 
(hemoglobin level <11.0 g/dL), and 4 (25%) had a 
hemoglobin level <10 g/dL. All children with P. knowlesi 
infection had a hemoglobin minimum level <11.0 g/dL, 
and 10 (63%) had a hemoglobin minimum level <10 g/dL. 
The lowest hemoglobin level was found in an 8-year-old 
boy: 8.3 g/dL at admission, 6.4 g/dL on day 3, and 7.2 g/
dL on day 6, the day before discharge. His parasite count at 
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Figure 1. Distribution of malaria cases diagnosed by 
microscopy and PCR among all age groups, Kudat, 
Malaysia, January 1–November 30, 2009. P.m., 
Plasmodium malariae; P.f., P. falciparum; P.v., P. vivax; 
P.k., P. knowlesi; neg, negative.
Figure 2. Distribution of malaria cases diagnosed by microscopy 
and PCR among children <15 years of age, Kudat, Malaysia, 
January 1–November 30, 2009. P.m., Plasmodium malariae; P.f., P. 
falciparum; P.v., P. vivax; P.k., P. knowlesi.
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admission (14,400 parasites/μL) was the highest recorded 
in this study.
In addition, severe anemia (hemoglobin 6.0 g/dL at 
admission; minimum level 4.9 g/dL on day 1 requiring 
transfusion) occurred in a second child with positive results 
for P. knowlesi by microscopy (this child was not included 
in the fi nal analysis because of lack of PCR confi rmation). 
Among children with P. knowlesi infection, a lower 
hemoglobin minimum level was associated with higher 
parasite density at admission (p = 0.001). All children with 
P. falciparum infection had hemoglobin levels at admission 
<11.0 g/dL; 10 (71%) had hemoglobin levels <10 g/dL, and 
5 (36%) had severe anemia (hemoglobin <7.1 g/dL). Severe 
anemia developed in a sixth child after admission. Four 
children received transfusions, with hemoglobin levels 
of 4.8–6.1 g/dL at admission. Children with P. knowlesi 
malaria took longer to reach their hemoglobin minimum 
level than did children with P. falciparum malaria (2.6 vs 
1.5 days; p = 0.02).
Thrombocytopenia
All children with P. knowlesi malaria had 
thrombocytopenia. Fifteen children (94%) had a platelet 
count <150,000/μL at admission, and the remaining child 
exhibited thrombocytopenia within 1 day. The lowest 
platelet count recorded was 28,000/μL. Platelet count was 
not correlated with hemoglobin level. Thrombocytopenia 
was less common in children with P. falciparum; 7 (50%) 
had platelet counts <150,000/μL at admission or during 
hospitalization and the lowest platelet count was 47,000/μL. 
Children with P. knowlesi malaria had a lower lymphocyte 
count minimum than those with P. falciparum malaria (1.6 
vs. 2.4 × 103/μL; p = 0.01).
Response to Treatment
Most (81%) children with P. knowlesi malaria were 
given oral chloroquine and primaquine for 3 days, and 
these children had a median parasite clearance time of 
2 days (Table 2). The longest parasite clearance time 
with chloroquine and primaquine was 5 days in the 
aforementioned 8-year-old boy with the highest admission 
parasitemia level (14,400/μL) and the lowest minimum 
hemoglobin level (6.4 g/dL). Three children with P. 
knowlesi infection were given oral quinine, and parasites 
cleared within 2 days. Among the 11 children with P. 
knowlesi and parasite densities accurately assessed at 
admission, the correlation between parasite density and 
parasite clearance time was signifi cant (p = 0.002).
Children with P. falciparum malaria were given 
a variety of treatment regimens. Most (71%) received 
a regimen that contained quinine, 7 (50%) children 
received sulfadoxine/pyrimethamine, 6 (43%) received 
primaquine, and 5 (36%) were given chloroquine. Only 
5 (36%) received artemisinin-based combination therapy. 
Parasite clearance times were signifi cantly slower among 
children with P. falciparum malaria, with a median of 5 
days until the fi rst negative smear; in 4 children (29%), 
it took >10 days for parasites be cleared. Children with 
P. knowlesi malaria had signifi cantly shorter hospital 
admissions (median 4 days, IQR 4–5 days) than did 
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Table 1. Demographic data, clinical features of infection, and laboratory values in 14 cases of Plasmodium falciparum malaria and 16 
cases of PCR-confirmed P. knowlesi malaria in children, Kudat, Malaysia, January 1–November 30, 2009* 
Characteristic P. knowlesi, n =16 P. falciparum, n =14 p value
Age, y 
 Mean (SD) 8.9 (2.5) 5.4 (3.2) 0.002
  Range 4–14 0.75–11 
Male sex, no. (%) 8 (50) 7 (50) 1.00
Living in Banggi, no. (%) 0 (0) 10 (71.4) <0.001
Duration of fever, d, median (IQR) 4 (3–6) 6.5 (4–7)  0.12 
Examination findings at admission 
 Temperature, oC, median (IQR)  37.9 (37.0–39.1) 37.0 (37.0–37.4) 0.07
 Heart rate, beats/min, mean (SD) 110 (24) 119 (15) 0.24
 Respiratory rate, beats/min, mean (SD) 27.8 (3.9) 32 (3.8) 0.01
 Systolic blood pressure, mm Hg, mean (SD)  105 (8.3) 98 (11.2) 0.06
Laboratory results 
 Hemoglobin d 0, g/dL, median (IQR) 10.7 (10.0–11.4) 8.5 (6.1–10.5) 0.001
 Hemoglobin minimum level, g/dL, median (IQR) 9.7 (8.4–10.2) 7.15 (6.1–9.3) 0.035
 Day of hemoglobin minimum level, mean (SD) 2.6 (1.03) 1.5 (1.3) 0.022
 Lymphocyte count d 0, u 103/μL, median (IQR) 2.0 (1.7–2.3) 2.5 (2.0–4.6) 0.09
 Lymphocyte minimum level, u 103/μL, median (IQR) 1.6 (1.3–2.2) 2.4 (1.9–3.9) 0.01
 Day of lymphocyte minimum level, median (IQR) 1 (0–1) 1.5 (0–3) 0.19
 Thrombocyte count d 0, u 103/μL, median (IQR) 89.5 (72.0–118.5) 171.5 (98–271) 0.038
 Thrombocyte count minimum level, u 103/μL, median (IQR) 76.5 (68.5–110.0) 156 (98–227) 0.014
 Day of thrombocyte count minimum level, median (IQR) 1 (1–1) 0.5 (0–2) 0.67
*IQR, interquartile range. Boldface indicates statistical significance. 
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children with P. falciparum malaria (median 7 days, IQR 
5–10 days).
Discussion
P. knowlesi was the most common cause of malaria in 
adults and children in the Kudat region in Sabah, Malaysian 
Borneo. Although those with P. knowlesi infections had an 
older age distribution than did those with P. falciparum 
infections, the species still caused 63% of all malaria cases 
among children <15 years. Although nearly all previous 
reported cases of knowlesi malaria have been in adults, 
14% of all knowlesi cases in Kudat occurred in children. 
In children, P. knowlesi most often caused uncomplicated 
malaria, which responded well to chloroquine. Nevertheless, 
knowlesi malaria was associated with substantial illness 
in children, with all PCR-confi rmed P. knowlesi–infected 
children being anemic at admission or during hospital stay.
In the only other report of knowlesi malaria in children, 
a prospective study of adult knowlesi malaria in Sarawak 
reported the exclusion of 8 children <15 years with P. 
knowlesi infection, comprising 7% of all knowlesi cases 
(3). The clinical and laboratory features of P. knowlesi 
malaria in children have not been described. Consistent 
with the reported features of P. knowlesi malaria in adults 
(3), the disease in most children was uncomplicated. In 
adults with knowlesi malaria, increasing age is a risk factor 
for severe disease. Although the numbers are small, none of 
the children had severe manifestations of knowlesi malaria 
that have been reported in adults (3), such as acute lung 
injury or acute renal failure. In falciparum malaria, these 
conditions are also largely confi ned to adults (21); anemia, 
coma, and acidosis-related respiratory distress are the major 
manifestations of severe falciparum malaria in children. No 
child with knowlesi malaria exhibited coma or respiratory 
distress; however, anemia developed in all children with 
knowlesi malaria, with the hemoglobin concentration in 
1 patient (6%) falling to <7.0 g/dL. Anemia was more 
common in children than has been previously described in 
knowlesi malaria in adults (3). 
Thrombocytopenia was found at admission in nearly 
all (94%) children with P. knowlesi malaria, in contrast 
to only half of the children with P. falciparum malaria. 
Although the cause is unclear, thrombocytopenia is also 
nearly universal in infected adults (3), which makes it a 
characteristic feature of P. knowlesi infection across all 
age groups. The role of thrombocytopenia and platelet 
activation in the pathogenesis of knowlesi malaria requires 
further investigation.
Most children with P. knowlesi malaria had an adequate 
response to a 3-day regimen of treatment with chloroquine 
and primaquine, although the mean parasite clearance time 
of 2 days was longer than the 90% parasite clearance time 
of 10.3 hours that was recently reported in adults (25). One 
child who received chloroquine and primaquine, and had a 
high parasite count at admission, required 5 days to clear 
parasites. Standard Ministry of Health pediatric dosing 
regimens of chloroquine are used in Kudat; however, 
posttreatment vomiting or inadequate blood concentrations 
could not be excluded. Prospective studies that evaluate the 
response to chloroquine and artemisinin-based combination 
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Table 2. Malaria treatment according to Plasmodium species and response to treatment in children, Kudat, Malaysia, January 1–
November 30, 2009* 
Species and treatment regimen No. (%) patients Days until negative smear† 
P. knowlesi, n = 16 
 3 days CQ/PQ  13 (81) 2 (2–3, 1–5) 
 Oral Q 2 (13) 2, 2 
 IV Q 1 (6) 2
 All 2 (2–3, 1–5) 
P. falciparum, n = 14 
 3 days CQ/PQ o oral Q  2 (14) 5, 5 
 Oral Q o AL 1 (7) 3
 SP/PQ o AM 1 (7) 8
 SP/PQ 2 (14) 1, 2 
 SP/PQ o CQ/Q o AL 1 (7) 3
 SP/PQ o CQ/IV Q o AL  1 (7) 5
 SP/PQ o CQ/IV Q o oral Q 1 (7) 3
 SP/PQ o oral Q o IV Q o oral Q 1 (7) 16
 IV Q o oral Q 2 (14) 1, 10 
 IV Q o oral Q/PQ 1 (7) 11
 Oral Q/PQ o AM 1 (7) 10
 All 5 (3–10, 1–16)‡ 
*IQR, interquartile range; CQ, chloroquine; PQ, primaquine; Q, quinine; IV, intravenous; AL, artemether/lumefantrine; SP, 
sulfamethoxazole/pyrimethamine; AM, artesunate/mefloquine. 
†Values are mean (IQR, range) by category or days by patient. 
‡p value = 0.009 for days until negative smear for P. falciparum vs. P. knowlesi.
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therapy in pediatric knowlesi malaria are required. Children 
with P. falciparum malaria received many different 
treatment regimens and took signifi cantly longer to clear 
their parasites. Less than half received the recommended 
artemisinin-based combination therapy, and only after 
alternative treatments failed. Children with P. falciparum 
malaria had signifi cantly longer hospital stays, likely related 
at least in part to suboptimal treatment regimens. This 
fi nding highlights the importance of increasing the usage 
of artemisinin-based combination therapy for falciparum 
malaria in district hospitals in Sabah and elsewhere.
Our study had several limitations. First, PCR was only 
performed for 73% of cases across all age groups, and this 
limited our ability to accurately determine the true proportion 
of disease caused by P. knowlesi. Furthermore, although 
PCR was performed on samples from most children with P. 
knowlesi malaria, only 1 child with P. falciparum malaria 
had PCR performed. Our analysis, therefore, compared 
children with PCR-confi rmed knowlesi malaria to children 
with falciparum malaria diagnosed by either microscopy or 
PCR. Some of those children with a diagnosis of falciparum 
malaria may have actually had knowlesi malaria, and the 
differences found between these 2 species may therefore be 
minimum estimates. The retrospective design of our study 
also limited our ability to collect standardized clinical 
information.
This study demonstrates that P. knowlesi has become 
the predominant malaria species in the Kudat region, 
estimated by results of microscopy, PCR, or both, as 
contributing to 87% of all malaria cases, a higher proportion 
than that reported elsewhere in Malaysian Borneo. The 
emerging dominance of P. knowlesi in Malaysian Borneo 
has been hypothesized to result from the following 
factors: changing patterns of human exposure to monkeys 
and vectors (26) because of deforestation, and potentially 
reduced competition or cross-species protection from P. 
vivax and P. falciparum as a result of a 40-fold reduction 
in the prevalence of these species in Sabah and Sarawak 
during 1960–2006 following intensive malaria control 
efforts (27). The paucity of P. vivax in Kudat was 
particularly notable.
Previous reports of adult disease have been from 
communities adjacent to rainforests (3). Kudat is a coastal 
rural farming area with varied land use and vegetation 
patterns and with minimal remaining regrowth forest. 
Although our retrospective study did not gather detailed 
travel or exposure histories, it is likely that most pediatric 
infections were locally acquired and that infections with 
P. knowlesi did not occur solely in those spending time 
in forested areas. Macaque monkeys, the natural hosts of 
P. knowlesi, are widely distributed in different habitats 
throughout the Kudat area and are frequently domesticated. 
The major vectors of P. knowlesi in forested areas of 
Sarawak, Anopheles latens mosquitoes, disappear with 
deforestation, but vectors capable of transmitting P. 
knowlesi, An. balabacencis mosquitoes (26), do persist 
at lower densities in largely deforested areas of Sabah 
(28,29). In notable contrast to P. falciparum malaria, 
pediatric knowlesi malaria was restricted to children of 
school age. Further studies will be required to characterize 
the transmission patterns, vectors, and risk factors for P. 
knowlesi in deforested areas of Malaysia.
Conclusions
P. knowlesi is the most common cause of malaria 
in adults and children in the Kudat region of Sabah, a 
rural coastal deforested region. Consistent with previous 
studies in adults (3), we found that P. knowlesi in children 
most often caused uncomplicated malaria that responded 
adequately to chloroquine and primaquine. Anemia was 
common in children and knowlesi infection was associated 
with moderately severe anemia. Thrombocytopenia was 
universal and is characteristic of knowlesi malaria across 
all age groups. Larger prospective clinical studies are 
needed to describe more fully the epidemiology of P. 
knowlesi malaria in children, the full spectrum of clinical 
disease and the transmission patterns in nonforested areas 
such as Kudat.
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